Ładuje się......
Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE
OBJECTIVE: Glucocorticoids (GCs) are used as standard treatment for acute attacks of multiple sclerosis (MS). However, GCs eventually lose efficacy and do not prevent disease progression. Macrophage migration inhibitory factor (MIF) is the only known proinflammatory cytokine induced by GCs that inhi...
Zapisane w:
| Wydane w: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Lippincott Williams & Wilkins
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529283/ https://ncbi.nlm.nih.gov/pubmed/26280015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000139 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|